Table 3.
Summary of PRECIS and practical feasibility composite mean scores (and standard deviations) by study characteristics
| Scoring criteria | Intervention topic | Cancer control continuum | eHealth modality | Tailored | Intervention setting | Study design | Target population | Year published | Translation phase |
|---|---|---|---|---|---|---|---|---|---|
| Cancer screening (n = 12)a | Primary prevention (n = 78)a | Computer-based, CD-ROM and multimedia (n = 10) | No (n = 65) | Healthcare (n = 35) | RCT (n = 99) | At risk (n = 58) | 2001–2005 (n = 44) | T1 (n = 97) | |
| PRECIS | 3.2 (0.6) | 3.1 (0.5) | 3.2 (0.7) | 3.1 (0.6) | 3.1 (0.3) | 3.1 (0.5) | 3.1 (0.5) | 3.2 (0.6) | 3.1 (0.5) |
| Feasibility | 2.1 (0.5) | 1.9 (0.3) | 2.3 (0.6) | 2 (0.5) | 2.1 (0.5)* | 2 (0.4) | 2.1 (0.4) | 2.1 (0.5)* | 1.9 (0.4)* |
| Diet/nutrition (n = 19) | Screening (n = 12)a | CT-phone/IVR (n = 7) | Yes (n = 48) | Community (n = 51) | Quasi (n = 9) | Healthy (n = 44) | 2006–2010 (n = 69) | T2+ (n = 16) | |
| PRECIS | 3.1 (0.7) | 3.2 (0.6) | 3.0 (0.9) | 3.1 (0.5) | 3.1 (0.3) | 3.4 (0.6) | 3.2(0.6) | 3.1 (0.5) | 3.1 (0.6) |
| Feasibility | 1.9 (0.4) | 2.1 (0.5) | 2.1 (0.5) | 2 (0.4) | 2 (0.4)* | 2.1 (0.3) | 1.8 (0.3)* | 1.9 (0.4)* | 2.2 (0.5)* |
| Multicomponent (n = 13)a | Disease management (n = 21) | CT-print (n = 7) | Schools (n = 7) | GRT (n = 5) | Diseased (n = 11) | ||||
| PRECIS | 3.2 (0.6) | 3.2 (0.5) | 3.3 (0.4) | 3 (0.6) | 3.1 (0.4) | 3.2 (0.5) | |||
| Feasibility | 1.8 (0.3) | 2.1 (0.4) | 2.1 (0.2) | 1.6 (0.2)* | 2.2 (0.5) | 2.2 (0.6)* | |||
| Obesity/overweight (n = 19) | Survivorship (n = 3) | CT-web/email (n = 31) | Workplace (n = 20) | ||||||
| PRECIS | 3.1 (0.5) | 3.3 (0.7) | 3.2 (0.5) | 3.2 (0.6) | |||||
| Feasibility | 2.1 (0.4) | 2.4 (1.1) | 1.9 (0.4) | 1.8 (0.4) | |||||
| Physical activity (n = 23) | Mobile phone/text (n = 7) | ||||||||
| PRECIS | 3.1 (0.4) | 3.2 (0.4) | |||||||
| Feasibility | 1.8 (0.3) | 1.9 (0.5) | |||||||
| Smoking (n = 18) | Multiple (n = 13) | ||||||||
| PRECIS | 2.9 (0.6) | 3.1(0.5) | |||||||
| Feasibility | 2 (0.3) | 2 (0.4) | |||||||
| Other (n = 10) | Web-based/email (n = 38) | ||||||||
| PRECIS | 3.2 (0.6) | 3 (0.5) | |||||||
| Feasibility | 2.3 (0.7) | 1.9 (0.4) |
IVR Interactive voice response, CT computer-tailored, GRT group randomized trial, Quasi quasiexperimental, RCT randomized-control trial, T1 efficacy studies, effectiveness, dissemination and implementation, and scale-up studies
aStudy counted in multiple areas within study characteristic
*p = 0.05 (statistically significant difference within study characteristic)